Probiotics Drug Interactions, Uses, Effectiveness, Safety & More
What is this page for?
First and foremost: how Probiotics interacts with medications. The heart of this page is the interaction list — every drug Probiotics is known to interact with, and how serious each one is.
But these pages have grown well beyond that into a full monograph — what Probiotics is, what people use it for and how strong the evidence is, its safety and side effects, and answers to the questions we’re asked most — written and reviewed by the clinical staff at HelloPharmacist. It’s educational information from our licensed clinical databases, not medical advice, and we don’t sell or endorse products. Our editorial policy
Check Probiotics against your medication
Add one medicationProbiotics Drug Interactions: The Bottom Line
From the HelloPharmacist Editorial Team · Updated July 2026Based on the available evidence, the overall risk of a clinically significant Probiotics drug interaction appears low for most people, because the listed interactions mainly affect how well the probiotic works, not the safety or levels of the medications themselves. None of the interactions are rated major, and every concern in the data runs in one direction: the medication may reduce the probiotic's benefit.
Antibiotics are the best-documented concern. Since most probiotics are live bacteria, an antibiotic taken at the same time can kill many of those organisms, although human research suggests the probiotic's benefit may still hold up when the two are taken together. Antifungal medications raise a similar but more theoretical issue for yeast-based probiotics such as Saccharomyces boulardii, because those products are fungi rather than bacteria. In neither case does the probiotic appear to make the medication itself less safe or less effective.
The long list of interacting medications mostly reflects these two broad drug families rather than hundreds of separate problems. The concern is largely theoretical, built on the simple idea that drugs designed to kill microbes could also kill the live organisms in a probiotic. Nothing in the data suggests probiotics change how the body absorbs or clears medications.
Based on HelloPharmacist’s Probiotics interaction data and reviewed under our editorial standards.
Drugs that interact with Probiotics
222 medications have a known interaction with Probiotics, graded by severity. Select any drug for the full evidence-based detail.
Don’t want to scroll the list? Just ask.
Tell us the medications you take and we’ll check each one against Probiotics using our pharmacist-reviewed interaction data.
AI summaries are generated from our Probiotics interaction data for education only — always confirm with your pharmacist. How we use AI
No drugs match “”.
What Severity, Likelihood & Evidence Mean
Severity — How Serious It Can Be
- Major. Clinically significant; generally best avoided, or used only under direct professional supervision.
- Moderate. May need monitoring, a dose adjustment, or separating the times you take each one.
- Minor. Generally not clinically significant, but still worth noting and mentioning to your pharmacist.
- No known interaction. Checked against our sources with nothing documented — not the same as proven safety.
Likelihood — How Well It’s Documented
- Likely. Well-controlled human studies have demonstrated the likely existence of this interaction
- Probable. Interaction has not been documented in well-controlled studies, however, the interaction has been demonstrated in some small human studies or in controlled animal studies in conjunction with multiple case reports.
- Possible. Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists
- Unlikely. Interaction has been demonstrated in animal or in lab research but has been shown not to occur in humans.
Where This Data Comes From
- Interaction records are evidence-graded and sourced from the Natural Medicines database (TRC Healthcare), the same reference used by pharmacists and hospitals.
- Each drug listed above links to the full report for that exact Probiotics combination — clinical detail, likelihood, evidence level, and citations.
- Content is reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.
The kinds of drugs Probiotics affects
Every type of medication (drug category) Probiotics is known to interact with. Open any category for the detail — or search your exact drug in the checker above.
Antibiotic Drugs
Theoretically, taking antibiotic drugs with certain probiotics might decrease the effectiveness of probiotics.
Many probiotics are bacteria. Since these preparations usually contain live and active organisms, simultaneously taking antibiotics might kill a significant number of sensitive organisms. Human research shows that taking probiotic concurrently with antibiotic treatment does not affect the diversity of the gut microbiome compared with antibiotic treatment in the absence of probiotics. Tell patients to separate administration of antibiotics and these preparations by at least two hours.
Antifungals
Theoretically, taking antifungals with certain probiotics might decrease the effectiveness of probiotics.
Some probiotics such as Saccharomyces boulardii are fungi. Therefore, simultaneously taking antifungals might kill a significant number of these organisms.
Probiotics: Uses, Safety & Side Effects
Probiotics are live 'friendly' microbes that may help certain digestive conditions, such as antibiotic-associated diarrhea and some cases of IBS, though benefits depend heavily on the specific strain and dose. They are generally well tolerated for healthy people but should be used with caution by those with serious illness or weakened immune systems. Talk with your pharmacist or doctor to pick a product that matches your goal.
- Part used
- Live microorganisms (bacteria and yeasts)
- Common forms
- Capsules, tablets, powders, chewables, gummies, drops, and fermented foods (yogurt, kefir, kombucha, sauerkraut)
- Digestive health and regularity
- Antibiotic-associated diarrhea
- Irritable bowel syndrome (IBS)
- Vaginal and urinary health
- Immune support
- General gut microbiome balance
Popular and traditional uses — not proof it works. See “Uses & effectiveness” below for the evidence.
Generally well tolerated in healthy people, but those who are seriously ill or immunocompromised should use them only under medical guidance.
When Lactobacillus acidophilus, Lacticaseibacillus casei, Lacticaseibacillus paracasei, Lactiplantibacillus plantarum, Ligilactobacillus salivarius, L...
Read the full pregnancy detailWhen Lacticaseibacillus paracasei, Limosilactobacillus fermentum, Limosilactobacillus reuteri, Lacticaseibacillus rhamnosus, and Bifidobacterium longu...
Read the full breastfeeding detailPregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center). Safety guidance is general; always confirm with your pharmacist or doctor for your situation.
Overview
Probiotics are live microorganisms—mostly bacteria, and sometimes yeasts—that are taken in hopes of providing a health benefit, usually for the digestive system. They are not a single plant or herb. Common probiotic groups include Lactobacillus, Bifidobacterium, and the yeast Saccharomyces boulardii.
These microbes occur naturally in the human gut and in many fermented foods like yogurt, kefir, sauerkraut, kimchi, and kombucha. They are also sold as dietary supplements in capsules, powders, and gummies.
People take probiotics to support digestion, ease certain types of diarrhea, and promote a balanced gut microbiome. Because there are many different species and strains, one product is not the same as another—each strain may act differently in the body.
How it works
Probiotics are thought to work in several ways, though much of this comes from laboratory and animal research. They may help by crowding out harmful bacteria, competing for nutrients and space in the gut, and producing substances that make it harder for bad microbes to grow.
Some strains may strengthen the gut lining (the barrier that keeps the inside of your intestines separate from the rest of your body) and interact with the immune system. They can also produce short-chain fatty acids and other compounds that may support gut cells.
Because effects depend on the exact strain, dose, and a person's own microbiome, the way one probiotic works may not apply to another. Many proposed mechanisms have not been fully confirmed in humans.
Does Probiotics work?
How to read these evidence grades
Natural Medicines’ 7-point scale. We show each rating’s label word-for-word.
Possibly Effective Abdominal pain
Oral probiotics containing Limosilactobacillus reuteri seem to reduce abdominal pain in children 4 years and up. It is unclear if other probiotics are beneficial for abdominal pain.
Possibly Effective Antibiotic-associated diarrhea
Oral probiotics, especially Lacticaseibacillus rhamnosus, Lactobacillus acidophilus, and Saccharomyces boulardii, seem to reduce the risk of antibiotic-associated diarrhea (AAD) in adults and children.
Possibly Effective Atopic dermatitis (eczema)
Oral probiotics, especially some combination products of lactobacilli species, seem to be beneficial for atopic dermatitis prevention in children. However, evidence on the use of oral probiotics for the treatment of atopic dermatitis is conflicting.
Possibly Effective Atopic disease
Oral Lacticaseibacillus rhamnosus GG seems to be beneficial for the prevention of atopic disease in children. However, it is unclear if other probiotics are beneficial.
Possibly Effective Bacterial vaginosis
Oral or vaginal probiotics, alone or in combination with antibiotics, seem to be beneficial for bacterial vaginosis.
Possibly Effective Clostridioides difficile infection
Taking oral probiotics with antibiotics might reduce the risk of an initial C. difficile infection in certain high-risk patients. Also, in some patients, oral Saccharomyces boulardii might reduce the risk of C. difficile infection RECURRENCE. It is unclear if other probiotics are beneficial for the prevention of recurrence.
Possibly Effective Colic
Oral Limosilactobacillus reuteri DSM 17938 and Bifidobacterium animalis subsp. lactis BB-12 seem to be beneficial for colic treatment. However, it is unclear if oral probiotics are beneficial for colic prevention.
Possibly Effective Constipation
Oral probiotics seem to be beneficial for constipation in adults. It is unclear if probiotics are beneficial for constipation in children.
Possibly Effective Helicobacter pylori
Oral probiotics, in conjunction with most standard H. pylori eradication therapies, seem to be beneficial for improving eradication rates.
Possibly Effective Hepatic encephalopathy
Oral probiotics seem to be beneficial for hepatic encephalopathy.
Possibly Effective Hypercholesterolemia
Oral probiotics seem to be beneficial for hypercholesterolemia.
Possibly Effective Irritable bowel syndrome (IBS)
Oral probiotics seem to be beneficial for the relief of global IBS symptoms, such as abdominal pain.
Possibly Effective Liver transplant
Oral probiotics seem to be beneficial for patients undergoing liver transplant.
Possibly Effective Necrotizing enterocolitis (NEC)
Oral probiotics, especially multi-strain products, seem to be beneficial for the prevention of NEC in low-birth-weight infants. However, guidance among regulatory agencies and clinical organizations varies.
Possibly Effective Otitis media
Oral probiotics seem to be beneficial for the prevention of otitis media in children.
Possibly Effective Pouchitis
Combination oral probiotic products containing various strains of lactobacilli and bifidobacteria, usually along with Streptococcus thermophilus, seem to be beneficial for pouchitis.
Possibly Effective Radiation-induced diarrhea
Most research shows that oral probiotics are beneficial for preventing or treating radiation-induced diarrhea.
Possibly Effective Respiratory tract infections
Oral probiotics seem to be beneficial for respiratory tract infection prevention. It is unclear if oral probiotics are beneficial for respiratory tract infection treatment.
Possibly Effective Rotaviral diarrhea
Oral probiotics containing Saccharomyces boulardii seem to be beneficial for the treatment of rotaviral diarrhea in children. It is unclear if other probiotics are beneficial.
Possibly Effective Ulcerative colitis
Combination oral probiotic products containing various strains of lactobacilli and bifidobacteria seem to be beneficial for ulcerative colitis.
Possibly Ineffective Age-related cognitive decline
Oral probiotics containing Bifidobacterium breve do not seem to be beneficial for age-related cognitive decline. It is unclear if other probiotics may be beneficial.
Possibly Ineffective Crohn disease
Oral probiotics don't seem to be beneficial for inducing or maintaining remission of this condition.
Possibly Ineffective Exercise-induced respiratory infections
Oral probiotics don't seem to be beneficial for preventing respiratory infections related to exercise.
Possibly Ineffective Sepsis
Oral probiotics do not seem to be beneficial for preventing sepsis in preterm infants.
Possibly Ineffective Vaginal candidiasis
Oral or intravaginal probiotics do not seem to be beneficial for vaginal candidiasis.
Also studied for 38 conditions — evidence insufficient to rate
Insufficient Reliable Evidence To Rate Acne
Small clinical studies suggest that oral probiotics may be beneficial for acne.
Insufficient Reliable Evidence To Rate Allergic rhinitis (hay fever)
Oral probiotics seem to be modestly beneficial for allergic rhinitis. However, it is unclear if probiotics are beneficial in patients taking antihistamines.
Insufficient Reliable Evidence To Rate Anxiety
It is unclear if oral probiotics are beneficial for anxiety.
Insufficient Reliable Evidence To Rate Autism spectrum disorder
It is unclear if oral probiotics are beneficial for autism spectrum disorder.
Insufficient Reliable Evidence To Rate Cancer
It is unclear if taking probiotics reduces mortality from cancer.
Insufficient Reliable Evidence To Rate Cardiovascular disease (CVD)
It is unclear if taking probiotics prevents mortality from CVD.
Insufficient Reliable Evidence To Rate Chemotherapy-induced diarrhea
It is unclear if oral probiotics are beneficial for preventing chemotherapy-induced diarrhea.
Insufficient Reliable Evidence To Rate Child development
It is unclear if oral probiotics are beneficial for improving cognitive function in infants or children.
Insufficient Reliable Evidence To Rate Child growth
It is unclear if oral probiotics are beneficial for child growth.
Insufficient Reliable Evidence To Rate Coronavirus disease 2019 (COVID-19)
Most research suggests that oral probiotics might be beneficial for reducing COVID-19 symptoms. However, it is unclear if probiotics are beneficial for preventing clinical escalation or mortality.
Insufficient Reliable Evidence To Rate Critical illness (trauma)
It is unclear if oral probiotics are beneficial for critically ill patients.
Insufficient Reliable Evidence To Rate Dental caries
It is unclear if oral probiotics are beneficial for the prevention of dental caries.
Insufficient Reliable Evidence To Rate Depression
It is unclear if oral probiotics are beneficial for depression.
Insufficient Reliable Evidence To Rate Diabetes
It is unclear if oral probiotics are beneficial for the treatment of type 1 diabetes, type 2 diabetes, or gestational diabetes. Oral probiotics are unlikely to be beneficial for gestational diabetes prevention and some strains may increase the risk of other complications.
Insufficient Reliable Evidence To Rate Fetal and premature infant mortality
Oral probiotics, especially in combination treatments, may be beneficial for the prevention of mortality in premature infants, although the available research is conflicting.
Insufficient Reliable Evidence To Rate Food allergies
It is unclear if oral probiotics are beneficial for food allergies.
Insufficient Reliable Evidence To Rate Hypertension
Oral probiotics seem to have a modest beneficial effect on blood pressure.
Insufficient Reliable Evidence To Rate Lactose intolerance
It is unclear if oral probiotics are beneficial for lactose intolerance.
Insufficient Reliable Evidence To Rate Malnutrition
It is unclear if oral probiotics are beneficial for promoting growth in undernourished children.
Insufficient Reliable Evidence To Rate Metabolic syndrome
It is unclear if oral probiotics are beneficial for metabolic syndrome.
Insufficient Reliable Evidence To Rate Multiple sclerosis (MS)
It is unclear if oral probiotics are beneficial for MS.
Insufficient Reliable Evidence To Rate Nonalcoholic fatty liver disease (NAFLD)
It is unclear if oral probiotics are beneficial for NAFLD.
Insufficient Reliable Evidence To Rate Obesity
It is unclear if oral probiotics are beneficial for obesity.
Insufficient Reliable Evidence To Rate Oral mucositis
It is unclear if oral probiotics are beneficial for oral mucositis.
Insufficient Reliable Evidence To Rate Overall mortality
It is unclear if taking probiotics reduces the risk of mortality.
Insufficient Reliable Evidence To Rate Pancreatitis
It is unclear if taking probiotics is beneficial for acute pancreatitis.
Insufficient Reliable Evidence To Rate Parkinson disease
It is unclear if taking probiotics is beneficial for Parkinson disease.
Insufficient Reliable Evidence To Rate Periodontitis
It is unclear if oral or topical probiotics are beneficial for periodontitis.
Insufficient Reliable Evidence To Rate Polycystic ovary syndrome (PCOS)
It is unclear if oral probiotics are beneficial for PCOS.
Insufficient Reliable Evidence To Rate Postoperative infection
It is unclear if oral probiotics are beneficial for preventing postoperative infection; the available research is conflicting.
Insufficient Reliable Evidence To Rate Postoperative recovery
It is unclear if oral probiotics are beneficial for postoperative recovery.
Insufficient Reliable Evidence To Rate Postpartum depression
It is unclear if oral probiotics are beneficial for postpartum depression.
Insufficient Reliable Evidence To Rate Premature rupture of membranes (PROM)
It is unclear if vaginal probiotics are beneficial for PROM.
Insufficient Reliable Evidence To Rate Rheumatoid arthritis (RA)
It is unclear if oral probiotics are beneficial for RA.
Insufficient Reliable Evidence To Rate Small intestinal bacterial overgrowth (SIBO)
It is unclear if oral probiotics are beneficial for SIBO treatment or prevention.
Insufficient Reliable Evidence To Rate Travelers' diarrhea
It is unclear if oral probiotics are beneficial for the prevention of travelers' diarrhea.
Insufficient Reliable Evidence To Rate Urinary tract infections (UTIs)
It is unclear if oral or vaginal probiotics are beneficial for UTI prevention or recurrence; the available research is conflicting.
Insufficient Reliable Evidence To Rate Ventilator-associated pneumonia (VAP)
It is unclear if oral probiotics are beneficial for the prevention of VAP in critically ill patients.
Source & disclaimer. Effectiveness ratings and evidence summaries are provided by Natural Medicines (Therapeutic Research Center) and shown as licensed. Where Natural Medicines hasn’t rated a use, HelloPharmacist’s pharmacists may add their own reviewed rating and evidence (each such entry is labeled). This is educational information, not medical advice — talk with your pharmacist or doctor before starting, stopping, or changing a supplement.
Safety & precautions
For most healthy people, probiotics are considered generally safe when used as directed. However, certain groups should be cautious or avoid them unless a doctor advises otherwise.
People who are seriously ill, have weakened immune systems (for example from chemotherapy, HIV, or organ transplant), have central venous catheters, or are critically ill in the hospital face a small but real risk of serious infection from probiotic organisms. Premature infants are also a high-risk group.
For pregnancy and breastfeeding, probiotics are often considered low risk, but high-quality safety data are limited. To be safe, pregnant or nursing people should talk with their doctor before starting a probiotic. As with any supplement, choose a reputable brand, since product quality and the number of live organisms can vary.
Side effects
Side effects are usually mild and may include gas, bloating, and changes in bowel habits, especially in the first few days of use. These often settle as the body adjusts.
Rare but serious problems—such as bloodstream infections (bacteremia or fungemia)—have been reported mostly in people who are very ill or immunocompromised. If you develop a fever, severe abdominal pain, or feel unwell after starting a probiotic, stop using it and contact your healthcare provider.
Probiotics: Reported Adverse Effects
Documented safety reports on Probiotics from the evidence-graded Natural Medicines (TRC Healthcare) database, shown word-for-word from the licensed record.
Reports by conditionDermatitis Dermatologic
Orally, probiotics have been reported to cause rare cases of rash, itching and redness, and dermatitis. See individual topics for details.
- Begtrup LM, de Muckadell OB, Kjeldsen J, Christensen RD, Jarbøl DE. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial. Scand J Gastroenterol 2013;48(10):1127-35
- Hanifi A, Culpepper T, Mai V, et al. Evaluation of Bacillus subtilis R0179 on gastrointestinal viability and general wellness: a randomised, double-blind, placebo-controlled trial in healthy adults. Benef Microbes 2015;6(1):19-27.
- Merenstein DJ, Smith KH, Scriven M, Roberts RF, Sanders ME, Petterson S. The study to investigate the potential benefits of probiotics in yogurt, a patient-oriented, double-blind, cluster-randomised, placebo-controlled, clinical trial. Eur J Clin Nutr. 20
Diarrhea Gastrointestinal
Orally, gastrointestinal adverse effects such as diarrhea, dyspepsia, abdominal pain, nausea, vomiting, bloating, belching, and flatulence have been reported rarely with probiotics. See individual topics for details.
- Blumenthal M, ed. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Trans. S. Klein. Boston, MA: American Botanical Council, 1998.
- Phuapradit P, Varavithya W, Vathanophas K, et al. Reduction of rotavirus infection in children receiving bifidobacteria-supplemented formula. J Med Assoc Thai 1999;82:S43-8.
- Miele E, Pascarella F, Giannetti E. et al. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol 2009;104:437-43.
- Beerepoot MA, ter Riet G, Nys S, van der Wal WM, de Borgie CA, de Reijke TM,Prins JM, Koeijers J, Verbon A, Stobberingh E, Geerlings SE. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in p
- Chatterjee S, Kar P, Das T, Ray S, Gangulyt S, Rajendiran C, Mitra M. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated
- Krag A, Munkholm P, Israelsen H, von Ryberg B, Andersen KK, Bendtsen F. Profermin is efficacious in patients with active ulcerative colitis--a randomized controlled trial. Inflamm Bowel Dis. 2013;19(12):2584-92.
- Shavakhi A, Tabesh E, Yaghoutkar A, Hashemi H, Tabesh F, Khodadoostan M,Minakari M, Shavakhi S, Gholamrezaei A. The effects of multistrain probiotic compound on bismuth-containing quadruple therapy for Helicobacter pylori infection: a randomized placebo-c
- Taipale TJ, Pienihäkkinen K, Isolauri E, Jokela JT, Söderling EM. Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatr Res. 2016;79(1-1):65-9.
- Shahriari A, Karimi E, Shahriari M, Aslani N, Khooshideh M, Arab A. The effect of probiotic supplementation on the risk of gestational diabetes mellitus among high-risk pregnant women: A parallel double-blind, randomized, placebo-controlled clinical trial
- Freedman KE, Hill JL, Wei Y, et al. Examining the gastrointestinal and immunomodulatory effects of the novel probiotic Bacillus subtilis DE111. Int J Mol Sci 2021;22(5):2453.
- Luo C, Peng S, Li M, Ao X, Liu Z. The efficacy and safety of probiotics for allergic rhinitis: A systematic review and meta-analysis. Front Immunol 2022;13:848279.
- DI Pierro F, Criscuolo AA, Dei Giudici A, et al. Oral administration of Lactobacillus crispatus M247 to papillomavirus-infected women: results of a preliminary, uncontrolled, open trial. Minerva Obstet Gynecol 2021;73(5):621-631.
- Dellino M, Cascardi E, Laganà AS, et al. Lactobacillus crispatus M247 oral administration: Is it really an effective strategy in the management of papillomavirus-infected women?. Infect Agent Cancer 2022;17(1):53.
- Tasli L, Mat C, De Simone C, Yazici H. Lactobacilli lozenges in the management of oral ulcers of Behçet's syndrome. Clin Exp Rheumatol. 2006;24(5 Suppl 42):S83-6.
- Silva NLNV, Della Bona A, Cardoso M, et al. Lactobacillus brevis CD2 attenuates traumatic oral lesions induced by fixed orthodontic appliance: A randomized phase 2 trial. Orthod Craniofac Res. 2021;24(3):379-385.
- Mäkelä SM, Forssten SD, Kailajärvi M, et al. Effects of Bifidobacterium animalis ssp. lactis 420 on gastrointestinal inflammation induced by a nonsteroidal anti-inflammatory drug: A randomized, placebo-controlled, double-blind clinical trial. Br J Clin Ph
- Wildt S, Munck LK, Vinter-Jensen L, et al. Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis. Inflamm Bowel Dis 2006;12(5):395-401.
- Sadrin S, Sennoune S, Gout B, et al. A 2-strain mixture of Lactobacillus acidophilus in the treatment of irritable bowel syndrome: A placebo-controlled randomized clinical trial. Dig Liver Dis 2020;52(5):534-540.
- Wang Y, Zheng Y, Kuang L, et al. Effects of probiotics in patients with morbid obesity undergoing bariatric surgery: a systematic review and meta-analysis. Int J Obes (Lond) 2023;47(11):1029-1042.
Prematurity Immunologic
Since many probiotic preparations contain live and active microorganisms, there is some concern that they might cause pathogenic infection in some patients. Bacteremia and sepsis have been reported in patients with indwelling or central venous catheters or patients who are severely ill and/or immunocompromised, including preterm infants, that were using probiotic products. However, reports of pathogenic colonization in relatively healthy patients with intact immune systems who do not have indwelling or central venous catheters are extremely rare. See individual topics for details.
Rarely, oral use of Saccharomyces boulardii has been associated with fungemia in both immunocompromised and immunocompetent patients, including preterm infants. Numerous cases of Saccharomyces fungemia have been reported in critically ill intensive care unit (ICU) patients, particularly those with indwelling or central venous catheters, those receiving enteral feeding, or those receiving broad-spectrum antibiotics. Most infections occurred when packets of Saccharomyces powder were used or when Saccharomyces capsules were opened at the bedside.
- Saxelin M, Chuang NH, Chassy B, et al. Lactobacilli and bacteremia in southern Finland 1989-1992. Clin Infect Dis 1996;22:564-6.
- MacGregor G, Smith AJ, Thakker B, Kinsella J. Yoghurt biotherapy: contraindicated in immunosuppressed patients? Postgrad Med J 2002;78:366-7.
- Land MH, Rouster-Stevens K, Woods CR, et al. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005;115:178-81.
- De Groote MA, Frank DN, Dowell E, et al. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J 2005;24:278-80.
- Vahabnezhad E, Mochon AB, Wozniak LJ, Ziring DA. Lactobacillus bacteremia associated with probiotic use in a pediatric patient with ulcerative colitis. J Clin Gastroenterol. 2013;47(5):437-9.
- Pruccoli G, Silvestro E, Pace Napoleone C, Aidala E, Garazzino S, Scolfaro C. Are probiotics safe? Bifidobacterium bacteremia in a child with severe heart failure. Infez Med. 2019;27(2):175-178.
- Sendil S, Shrimanker I, Mansoora Q, Goldman J, Nookala VK. Lactobacillus rhamnosus bacteremia in an immunocompromised renal transplant patient. Cureus. 2020;12(2):e6887.
- Albarillo FS, Shah U, Joyce C, Slade D. Lactobacillus rhamnosus Infection: A single-center 4-year descriptive analysis. J Glob Infect Dis. 2020;12(3):119-123.
- Agrawal S, Tuchman ES, Bruce MJ, Theodorou ME. Fatal Lactobacillus endocarditis in a patient with transcatheter aortic valve replacement. BMJ Case Rep. 2020;13(11):e236835.
- Antoun M, Hattab Y, Akhrass FA, Hamilton LD. Uncommon pathogen, Lactobacillus, causing infective endocarditis: Case report and review. Case Rep Infect Dis. 2020;2020:8833948.
- Rossi F, Amadoro C, Gasperi M, Colavita G. Lactobacilli infection case reports in the last three years and safety implications. Nutrients. 2022;14(6):1178.
- Sakurai Y, Watanabe T, Miura Y, et al. Clinical and bacteriologic characteristics of six cases of Bifidobacterium breve bacteremia due to probiotic administration in the neonatal intensive care unit. Pediatr Infect Dis J 2022;41(1):62-65.
- Esaiassen E, Hjerde E, Cavanagh JP, Simonsen GS, Klingenberg C; Norwegian Study Group on Invasive Bifidobacterial Infections. Bifidobacterium bacteremia: Clinical characteristics and a genomic approach to assess pathogenicity. J Clin Microbiol. 2017;55(7)
- US Food and Drug Administration (FDA). Dear Healthcare Provider Letter: Warning Regarding Use of Probiotics in Preterm Infants. September 2023. Available at: https://www.fda.gov/media/172606/download?attachment. Accessed November 1, 2023.
- Pillai A, Tan J, Paquette V, Panczuk J. Does probiotic bacteremia in premature infants impact clinically relevant outcomes? A case report and updated review of literature. Clin Nutr ESPEN. 2020;39:255-259.
- Dani C, Coviello C C, Corsini I I, Arena F, Antonelli A, Rossolini GM. Lactobacillus Sepsis and Probiotic Therapy in Newborns: Two New Cases and Literature Review. AJP Rep. 2016;6(1):e25-9.
- Zbinden A, Zbinden R, Berger C, Arlettaz R. Case series of Bifidobacterium longum bacteremia in three preterm infants on probiotic therapy. Neonatology 2015;107(1):56-9.
- Bertelli C, Pillonel T, Torregrossa A, et al. Bifidobacterium longum bacteremia in preterm infants receiving probiotics. Clin Infect Dis 2015;60(6):924-7.
- Esaiassen E, Cavanagh P, Hjerde E, Simonsen GS, Støen R, Klingenberg C. Bifidobacterium longum subspecies infantis bacteremia in 3 extremely preterm infants receiving probiotics. Emerg Infect Dis 2016;22(9):1664-6.
- Rubin IMC, Stevnsborg L, Mollerup S, Petersen AM, Pinholt M. Bacteraemia caused by Lactobacillus rhamnosus given as a probiotic in a patient with a central venous catheter: a WGS case report. Infect Prev Pract 2022;4(1):100200.
- Karime C, Barrios MS, Wiest NE, Stancampiano F. Lactobacillus rhamnosus sepsis, endocarditis and septic emboli in a patient with ulcerative colitis taking probiotics. BMJ Case Rep 2022;15(6):e249020.
- Sadowska-Krawczenko I, Paprzycka M, Korbal P, et al. Lactobacillus rhamnosus GG suspected infection in a newborn with intrauterine growth restriction. Benef Microbes. 2014;5(4):397-402.
- Rahman A, Alqaisi S, Nath J. A Case of Lactobacillus casei endocarditis associated with probiotic intake in an immunocompromised patient. Cureus. 2023;15(4):e38049.
- Lee ZY, Lew CCH, Ortiz-Reyes A, et al. Benefits and harm of probiotics and synbiotics in adult critically ill patients. A systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. Clin Nutr 2023;42(4):519-531.
- Tynkkynen S, Singh KV, Varmanen P. Vancomycin resistance factor of Lactobacillus rhamnosus GG in relation to enterococcal vancomycin resistance (van) genes. Int J Food Microbiol 1998;41:195-204.
- Klein G, Zill E, Schindler R, et al. Peritonitis associated with vancomycin-resistant Lactobacillus rhamnosus in a continuous ambulatory peritoneal dialysis patient; organism identification, antibiotic therapy, and case report. J Clin Microbiol 1998;36:
- Kalima P, Masterton RG, Roddie PH, et al. Lactobacillus rhamnosus infection in a child following bone marrow transplant. J Infect 1996;32:165-7.
- Goldin BR. Health Benefits of probiotics. Br J Nutr 1998;80:S203-7.
- Rautio M, Jousimies-Somer H, Kauma H, et al. Liver abscess due to Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin Infect Dis 1999;28:1159-60.
- Pasala S, Singer L, Arshad T, Roach K. Lactobacillus endocarditis in a healthy patient with probiotic use. IDCases. 2020;22:e00915.
- Franko B, Vaillant M, Recule C, Vautrin E, et al. Lactobacillus paracasei endocarditis in a consumer of probiotics. Med Mal Infect. 2013;43(4):171-3.
- Campbell RE, Miller A, Afroze A. Native valve endocarditis secondary to Lactobacillus paracasei bacteremia. Consultant. 2020;60(9):27-8.
- Kato K, Funabashi N, Takaoka H, et al. Lactobacillus paracasei endocarditis in a consumer of probiotics with advanced and severe bicuspid aortic valve stenosis complicated with diffuse left ventricular mid-layer fibrosis. Int J Cardiol. 2016;224:157-161.
- Niault M, Thomas F, Prost J, et al. Fungemia due to Saccharomyces species in a patient treated with enteral Saccharomyces boulardii. Clin Infect Dis 1999;28:930.
- Pletinex M, Legein J, Vandenplas Y. Fungemia with Saccharomyces boulardii in a 1-year-old girl with protracted diarrhea. J Pediatr Gastroenterol Nutr 1995;21:113-5.
- Fredenucci I, Chomarat M, Boucaud C, et al. Saccharomyces boulardii fungemia in a patient receiving ultra-levure therapy. Clin Infect Dis 1998;27:222-3.
- Elmer GW, McFarland LV, Surawicz CM, et al. Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients. Aliment Pharmacol Ther 1999;13:1663-8.
- Cesaro S, Chinello P, Rossi L, Zanesco L. Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii. Support Care Cancer 2000;8:504-5.
- Munoz P, Bouza E, Cuenca-Estrella M, et al. Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin Infect Dis 2005;40:1625-34.
- Lherm, T., Monet, C., Nougiere, B., Soulier, M., Larbi, D., Le Gall, C., Caen, D., and Malbrunot, C. Seven cases of fungemia with Saccharomyces boulardii in critically ill patients. Intensive Care Med 2002;28(6):797-801.
- Riquelme, A. J., Calvo, M. A., Guzman, A. M., Depix, M. S., Garcia, P., Perez, C., Arrese, M., and Labarca, J. A. Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients. J Clin.Gastroenterol. 2003;36(1):41-
- Cherifi, S., Robberecht, J., and Miendje, Y. Saccharomyces cerevisiae fungemia in an elderly patient with Clostridium difficile colitis. Acta Clin Belg. 2004;59(4):223-224.
- Ellouze O, Berthoud V, Mervant M, Parthiot JP, Girard C. Septic shock due to Sacccaromyces boulardii. Med Mal Infect. 2016;46(2):104-105.
- Appel-da-Silva MC, Narvaez GA, Perez LRR, Drehmer L, Lewgoy J. Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment. Med Mycol Case Rep. 2017;18:15-7.
- Roy U, Jessani LG, Rudramurthy SM, et al. Seven cases of Saccharomyces fungaemia related to use of probiotics. Mycoses 2017;60(6):375-380.
- Ventoulis I, Sarmourli T, Amoiridou P, et al. Bloodstream infection by Saccharomyces cerevisiae in two COVID-19 patients after receiving supplementation of Saccharomyces in the ICU. J Fungi (Basel). 2020;6(3):98.
- Borriello SP, Hammes WP, Holzapfel W, et al. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 2003;36:775-80.
- Marteau P, Seksik P. Tolerance of probiotics and prebiotics. J Clin Gastroenterol 2004;38:S67-9.
- Atici S, Soysal A, Karadeniz Cerit K, et al. Catheter-related Saccharomyces cerevisiae Fungemia Following Saccharomyces boulardii Probiotic Treatment: In a child in intensive care unit and review of the literature. Med Mycol Case Rep. 2017;15:33-35.
- Martin IW, Tonner R, Trivedi J, et al. Saccharomyces boulardii probiotic-associated fungemia: questioning the safety of this preventive probiotic's use. Diagn Microbiol Infect Dis. 2017;87(3):286-8.
- Romanio MR, Coraine LA, Maielo VP, Abramczyc ML, Souza RL, Oliveira NF. Saccharomyces cerevisiae fungemia in a pediatric patient after treatment with probiotics. Rev Paul Pediatr 2017;35(3):361-4.
Adverse-effects data: Natural Medicines, Therapeutic Research Center
Dosing
There is no single standardized dose for probiotics, because the right amount depends on the specific strain and the reason for use. Doses are often listed in colony-forming units (CFU), and products can range widely.
The best approach is to follow the directions on the product label and choose a product whose strain has been studied for your specific goal. A pharmacist can help you match a product to your needs and check that it is appropriate for you. Store probiotics as directed—some require refrigeration to keep the organisms alive.
Probiotics & Pregnancy
Probiotics & Breastfeeding
© 2026 Therapeutic Research Center
Pregnancy & lactation ratings: Natural Medicines, Therapeutic Research Center
References & further reading
The 77 references that drive our Probiotics monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.
- Blumenthal M, ed. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Trans. S. Klein. Boston, MA: American Botanical Council, 1998.
- Niault M, Thomas F, Prost J, et al. Fungemia due to Saccharomyces species in a patient treated with enteral Saccharomyces boulardii. Clin Infect Dis 1999;28:930.
- Pierce A. The American Pharmaceutical Association Practical Guide to Natural Medicines. New York: The Stonesong Press, 1999:19.
- Phuapradit P, Varavithya W, Vathanophas K, et al. Reduction of rotavirus infection in children receiving bifidobacteria-supplemented formula. J Med Assoc Thai 1999;82:S43-8.
- Pletinex M, Legein J, Vandenplas Y. Fungemia with Saccharomyces boulardii in a 1-year-old girl with protracted diarrhea. J Pediatr Gastroenterol Nutr 1995;21:113-5. DOI
- Fredenucci I, Chomarat M, Boucaud C, et al. Saccharomyces boulardii fungemia in a patient receiving ultra-levure therapy. Clin Infect Dis 1998;27:222-3.
- Elmer GW, McFarland LV, Surawicz CM, et al. Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients. Aliment Pharmacol Ther 1999;13:1663-8.
- Lewis SJ, Freedman AR. Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease. Aliment Pharmacol Ther 1998;12:807-22. PubMed
- Saxelin M, Chuang NH, Chassy B, et al. Lactobacilli and bacteremia in southern Finland 1989-1992. Clin Infect Dis 1996;22:564-6. PubMed
- Tynkkynen S, Singh KV, Varmanen P. Vancomycin resistance factor of Lactobacillus rhamnosus GG in relation to enterococcal vancomycin resistance (van) genes. Int J Food Microbiol 1998;41:195-204. PubMed
- Klein G, Zill E, Schindler R, et al. Peritonitis associated with vancomycin-resistant Lactobacillus rhamnosus in a continuous ambulatory peritoneal dialysis patient; organism identification, antibiotic therapy, and case report. J Clin Microbiol 1998;36:
- Kalima P, Masterton RG, Roddie PH, et al. Lactobacillus rhamnosus infection in a child following bone marrow transplant. J Infect 1996;32:165-7. PubMed
- Goldin BR. Health Benefits of probiotics. Br J Nutr 1998;80:S203-7. DOI
- Rautio M, Jousimies-Somer H, Kauma H, et al. Liver abscess due to Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin Infect Dis 1999;28:1159-60.
- Cesaro S, Chinello P, Rossi L, Zanesco L. Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii. Support Care Cancer 2000;8:504-5. PubMed
- MacGregor G, Smith AJ, Thakker B, Kinsella J. Yoghurt biotherapy: contraindicated in immunosuppressed patients? Postgrad Med J 2002;78:366-7. PubMed
- Borriello SP, Hammes WP, Holzapfel W, et al. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 2003;36:775-80. PubMed
- Marteau P, Seksik P. Tolerance of probiotics and prebiotics. J Clin Gastroenterol 2004;38:S67-9. PubMed
- Land MH, Rouster-Stevens K, Woods CR, et al. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005;115:178-81.
- De Groote MA, Frank DN, Dowell E, et al. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J 2005;24:278-80. PubMed
- Munoz P, Bouza E, Cuenca-Estrella M, et al. Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin Infect Dis 2005;40:1625-34. PubMed
- Miele E, Pascarella F, Giannetti E. et al. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol 2009;104:437-43. PubMed
- Xiao JZ, Takahashi S, Odamaki T, et al. Antibiotic susceptibility of bifidobacterial strains distributed in the Japanese market. Biosci Biotechnol Biochem. 2010;74(2):336-42. PubMed
- Lherm, T., Monet, C., Nougiere, B., Soulier, M., Larbi, D., Le Gall, C., Caen, D., and Malbrunot, C. Seven cases of fungemia with Saccharomyces boulardii in critically ill patients. Intensive Care Med 2002;28(6):797-801. PubMed
- Riquelme, A. J., Calvo, M. A., Guzman, A. M., Depix, M. S., Garcia, P., Perez, C., Arrese, M., and Labarca, J. A. Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients. J Clin.Gastroenterol. 2003;36(1):41- PubMed
- Cherifi, S., Robberecht, J., and Miendje, Y. Saccharomyces cerevisiae fungemia in an elderly patient with Clostridium difficile colitis. Acta Clin Belg. 2004;59(4):223-224. PubMed
- Beerepoot MA, ter Riet G, Nys S, van der Wal WM, de Borgie CA, de Reijke TM,Prins JM, Koeijers J, Verbon A, Stobberingh E, Geerlings SE. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in p DOI
- Begtrup LM, de Muckadell OB, Kjeldsen J, Christensen RD, Jarbøl DE. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial. Scand J Gastroenterol 2013;48(10):1127-35 PubMed
- Chatterjee S, Kar P, Das T, Ray S, Gangulyt S, Rajendiran C, Mitra M. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated
- Krag A, Munkholm P, Israelsen H, von Ryberg B, Andersen KK, Bendtsen F. Profermin is efficacious in patients with active ulcerative colitis--a randomized controlled trial. Inflamm Bowel Dis. 2013;19(12):2584-92. PubMed
- Shavakhi A, Tabesh E, Yaghoutkar A, Hashemi H, Tabesh F, Khodadoostan M,Minakari M, Shavakhi S, Gholamrezaei A. The effects of multistrain probiotic compound on bismuth-containing quadruple therapy for Helicobacter pylori infection: a randomized placebo-c
- Vahabnezhad E, Mochon AB, Wozniak LJ, Ziring DA. Lactobacillus bacteremia associated with probiotic use in a pediatric patient with ulcerative colitis. J Clin Gastroenterol. 2013;47(5):437-9. PubMed
- Ellouze O, Berthoud V, Mervant M, Parthiot JP, Girard C. Septic shock due to Sacccaromyces boulardii. Med Mal Infect. 2016;46(2):104-105.
- Merenstein DJ, Smith KH, Scriven M, Roberts RF, Sanders ME, Petterson S. The study to investigate the potential benefits of probiotics in yogurt, a patient-oriented, double-blind, cluster-randomised, placebo-controlled, clinical trial. Eur J Clin Nutr. 20 PubMed
- Appel-da-Silva MC, Narvaez GA, Perez LRR, Drehmer L, Lewgoy J. Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment. Med Mycol Case Rep. 2017;18:15-7. PubMed
- Atici S, Soysal A, Karadeniz Cerit K, et al. Catheter-related Saccharomyces cerevisiae Fungemia Following Saccharomyces boulardii Probiotic Treatment: In a child in intensive care unit and review of the literature. Med Mycol Case Rep. 2017;15:33-35. PubMed
- Martin IW, Tonner R, Trivedi J, et al. Saccharomyces boulardii probiotic-associated fungemia: questioning the safety of this preventive probiotic's use. Diagn Microbiol Infect Dis. 2017;87(3):286-8. PubMed
- Romanio MR, Coraine LA, Maielo VP, Abramczyc ML, Souza RL, Oliveira NF. Saccharomyces cerevisiae fungemia in a pediatric patient after treatment with probiotics. Rev Paul Pediatr 2017;35(3):361-4.
- Roy U, Jessani LG, Rudramurthy SM, et al. Seven cases of Saccharomyces fungaemia related to use of probiotics. Mycoses 2017;60(6):375-380.
- Taipale TJ, Pienihäkkinen K, Isolauri E, Jokela JT, Söderling EM. Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatr Res. 2016;79(1-1):65-9. PubMed
- Pruccoli G, Silvestro E, Pace Napoleone C, Aidala E, Garazzino S, Scolfaro C. Are probiotics safe? Bifidobacterium bacteremia in a child with severe heart failure. Infez Med. 2019;27(2):175-178.
- Sendil S, Shrimanker I, Mansoora Q, Goldman J, Nookala VK. Lactobacillus rhamnosus bacteremia in an immunocompromised renal transplant patient. Cureus. 2020;12(2):e6887. PubMed
- Albarillo FS, Shah U, Joyce C, Slade D. Lactobacillus rhamnosus Infection: A single-center 4-year descriptive analysis. J Glob Infect Dis. 2020;12(3):119-123. PubMed
- Pasala S, Singer L, Arshad T, Roach K. Lactobacillus endocarditis in a healthy patient with probiotic use. IDCases. 2020;22:e00915. PubMed
- Agrawal S, Tuchman ES, Bruce MJ, Theodorou ME. Fatal Lactobacillus endocarditis in a patient with transcatheter aortic valve replacement. BMJ Case Rep. 2020;13(11):e236835.
- Antoun M, Hattab Y, Akhrass FA, Hamilton LD. Uncommon pathogen, Lactobacillus, causing infective endocarditis: Case report and review. Case Rep Infect Dis. 2020;2020:8833948. PubMed
- Ventoulis I, Sarmourli T, Amoiridou P, et al. Bloodstream infection by Saccharomyces cerevisiae in two COVID-19 patients after receiving supplementation of Saccharomyces in the ICU. J Fungi (Basel). 2020;6(3):98. PubMed
- Shahriari A, Karimi E, Shahriari M, Aslani N, Khooshideh M, Arab A. The effect of probiotic supplementation on the risk of gestational diabetes mellitus among high-risk pregnant women: A parallel double-blind, randomized, placebo-controlled clinical trial PubMed
- Rossi F, Amadoro C, Gasperi M, Colavita G. Lactobacilli infection case reports in the last three years and safety implications. Nutrients. 2022;14(6):1178. PubMed
- Franko B, Vaillant M, Recule C, Vautrin E, et al. Lactobacillus paracasei endocarditis in a consumer of probiotics. Med Mal Infect. 2013;43(4):171-3. PubMed
- Campbell RE, Miller A, Afroze A. Native valve endocarditis secondary to Lactobacillus paracasei bacteremia. Consultant. 2020;60(9):27-8. DOI
- Kato K, Funabashi N, Takaoka H, et al. Lactobacillus paracasei endocarditis in a consumer of probiotics with advanced and severe bicuspid aortic valve stenosis complicated with diffuse left ventricular mid-layer fibrosis. Int J Cardiol. 2016;224:157-161. PubMed
- Sakurai Y, Watanabe T, Miura Y, et al. Clinical and bacteriologic characteristics of six cases of Bifidobacterium breve bacteremia due to probiotic administration in the neonatal intensive care unit. Pediatr Infect Dis J 2022;41(1):62-65. PubMed
- Esaiassen E, Hjerde E, Cavanagh JP, Simonsen GS, Klingenberg C; Norwegian Study Group on Invasive Bifidobacterial Infections. Bifidobacterium bacteremia: Clinical characteristics and a genomic approach to assess pathogenicity. J Clin Microbiol. 2017;55(7) PubMed
- Freedman KE, Hill JL, Wei Y, et al. Examining the gastrointestinal and immunomodulatory effects of the novel probiotic Bacillus subtilis DE111. Int J Mol Sci 2021;22(5):2453. PubMed
- Hanifi A, Culpepper T, Mai V, et al. Evaluation of Bacillus subtilis R0179 on gastrointestinal viability and general wellness: a randomised, double-blind, placebo-controlled trial in healthy adults. Benef Microbes 2015;6(1):19-27. PubMed
- Luo C, Peng S, Li M, Ao X, Liu Z. The efficacy and safety of probiotics for allergic rhinitis: A systematic review and meta-analysis. Front Immunol 2022;13:848279. PubMed
- DI Pierro F, Criscuolo AA, Dei Giudici A, et al. Oral administration of Lactobacillus crispatus M247 to papillomavirus-infected women: results of a preliminary, uncontrolled, open trial. Minerva Obstet Gynecol 2021;73(5):621-631. PubMed
- Dellino M, Cascardi E, Laganà AS, et al. Lactobacillus crispatus M247 oral administration: Is it really an effective strategy in the management of papillomavirus-infected women?. Infect Agent Cancer 2022;17(1):53. PubMed
- Tasli L, Mat C, De Simone C, Yazici H. Lactobacilli lozenges in the management of oral ulcers of Behçet's syndrome. Clin Exp Rheumatol. 2006;24(5 Suppl 42):S83-6.
- Silva NLNV, Della Bona A, Cardoso M, et al. Lactobacillus brevis CD2 attenuates traumatic oral lesions induced by fixed orthodontic appliance: A randomized phase 2 trial. Orthod Craniofac Res. 2021;24(3):379-385.
- Mäkelä SM, Forssten SD, Kailajärvi M, et al. Effects of Bifidobacterium animalis ssp. lactis 420 on gastrointestinal inflammation induced by a nonsteroidal anti-inflammatory drug: A randomized, placebo-controlled, double-blind clinical trial. Br J Clin Ph
- Wildt S, Munck LK, Vinter-Jensen L, et al. Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis. Inflamm Bowel Dis 2006;12(5):395-401. PubMed
- US Food and Drug Administration (FDA). Dear Healthcare Provider Letter: Warning Regarding Use of Probiotics in Preterm Infants. September 2023. Available at: https://www.fda.gov/media/172606/download?attachment. Accessed November 1, 2023.
- Pillai A, Tan J, Paquette V, Panczuk J. Does probiotic bacteremia in premature infants impact clinically relevant outcomes? A case report and updated review of literature. Clin Nutr ESPEN. 2020;39:255-259. PubMed
- Dani C, Coviello C C, Corsini I I, Arena F, Antonelli A, Rossolini GM. Lactobacillus Sepsis and Probiotic Therapy in Newborns: Two New Cases and Literature Review. AJP Rep. 2016;6(1):e25-9. PubMed
- Sadrin S, Sennoune S, Gout B, et al. A 2-strain mixture of Lactobacillus acidophilus in the treatment of irritable bowel syndrome: A placebo-controlled randomized clinical trial. Dig Liver Dis 2020;52(5):534-540. PubMed
- Zbinden A, Zbinden R, Berger C, Arlettaz R. Case series of Bifidobacterium longum bacteremia in three preterm infants on probiotic therapy. Neonatology 2015;107(1):56-9.
- Bertelli C, Pillonel T, Torregrossa A, et al. Bifidobacterium longum bacteremia in preterm infants receiving probiotics. Clin Infect Dis 2015;60(6):924-7. PubMed
- Esaiassen E, Cavanagh P, Hjerde E, Simonsen GS, Støen R, Klingenberg C. Bifidobacterium longum subspecies infantis bacteremia in 3 extremely preterm infants receiving probiotics. Emerg Infect Dis 2016;22(9):1664-6.
- Rubin IMC, Stevnsborg L, Mollerup S, Petersen AM, Pinholt M. Bacteraemia caused by Lactobacillus rhamnosus given as a probiotic in a patient with a central venous catheter: a WGS case report. Infect Prev Pract 2022;4(1):100200. PubMed
- Karime C, Barrios MS, Wiest NE, Stancampiano F. Lactobacillus rhamnosus sepsis, endocarditis and septic emboli in a patient with ulcerative colitis taking probiotics. BMJ Case Rep 2022;15(6):e249020.
- Sadowska-Krawczenko I, Paprzycka M, Korbal P, et al. Lactobacillus rhamnosus GG suspected infection in a newborn with intrauterine growth restriction. Benef Microbes. 2014;5(4):397-402. PubMed
- Rahman A, Alqaisi S, Nath J. A Case of Lactobacillus casei endocarditis associated with probiotic intake in an immunocompromised patient. Cureus. 2023;15(4):e38049. PubMed
- Éliás AJ, Barna V, Patoni C, et al. Probiotic supplementation during antibiotic treatment is unjustified in maintaining the gut microbiome diversity: a systematic review and meta-analysis. BMC Med 2023;21(1):262. PubMed
- Lee ZY, Lew CCH, Ortiz-Reyes A, et al. Benefits and harm of probiotics and synbiotics in adult critically ill patients. A systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. Clin Nutr 2023;42(4):519-531. PubMed
- Wang Y, Zheng Y, Kuang L, et al. Effects of probiotics in patients with morbid obesity undergoing bariatric surgery: a systematic review and meta-analysis. Int J Obes (Lond) 2023;47(11):1029-1042. PubMed
This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Brands that make products with Probiotics
6 brands in our database make a supplement containing Probiotics.
Supplement products with Probiotics
21 products in our database contain Probiotics. Open any to see its full ingredient list and every drug interaction we check.
Probiotics: Common Questions
What is Probiotics used for, and does it work?
Does Probiotics interact with prescription medications?
How are Probiotics interactions rated?
Is it safe to take Probiotics with my medications?
Where does this Probiotics interaction information come from?
What are Probiotics used for?
Are Probiotics safe to take every day?
Can I just eat yogurt instead of taking a supplement?
How long do Probiotics take to work?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Products that contain Probiotics
A rotating sample of real supplements in our database that list Probiotics — open any to see its full ingredients and every drug interaction we check.
- NDF Focus Citrus by Bioray Kids
- NDF Pooper Mango by Bioray Kids
- NDF+ Detox by Bioray Clinical
- Primary Detox by Bioray Adult Daily
- NDF Detox by Bioray Clinical
- Qultured Max Stress B by Quantum Nutrition Labs
- NDF Focus Citrus by Bioray Kids
- Primary Detox by Bioray
- Belly Mend by Bioray
- Max B-ND by Premier Research Labs
Have a question about Probiotics?
Our pharmacists answer your medication & supplement questions — free.